Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
7.92
-0.26 (-3.18%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $45.80 million as of April 28, 2026. Its market cap has increased by 33.72% in one year.
Market Cap
45.80M
Enterprise Value
-84.78M
1-Year Change
33.72%
Ranking
Category
Stock Price
$7.92
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $45.80M, a decrease of -89.27%. That is a compound annual growth rate of -39.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 47.30M | 40.73% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 50.62M |
| PDS Biotechnology | 50.26M |
| Atossa Therapeutics | 49.08M |
| Nutriband | 48.57M |
| Telomir Pharmaceuticals | 48.13M |
| Hyperion DeFi | 47.50M |
| Rein Therapeutics | 46.54M |
| Mereo BioPharma Group | 46.29M |